热门资讯> 正文
ReShape Lifesciences申请为股东出售1170万股普通股
2024-05-10 00:22
- ReShape Lifesciences (NASDAQ:RSLS) on Thursday filed a prospectus related to the proposed resale of 11.7M common shares by the selling stockholders.
- This prospectus is not an offer to sell these securities.
- SEC Filing
More on ReShape Lifesciences
- ReShape Lifesciences gets notice of allowance for additional U.S. patent
- ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
